Tregoning Kathleen
Insider CIK 1830764 · SPRO Director · CERE See Remarks · CMPS Director · KLRA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-07-06 | 2026-07-08 | 175,000 | — | $0 | 175,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2026-05-27 | 2026-05-29 | 41,119 | — | $0 | 41,119 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 614,428 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 59,171 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 10,666 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 59,171 | — | $0 | 59,171 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 35,604 | $1.12 | $39.9K | 35,604 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-26 | 2023-12-28 | 3,150 | — | $0 | 255,082 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-26 | 2023-12-28 | 3,150 | $10.05 | $31.7K | 10,666 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-20 | 2023-12-21 | 6,288 | $41.42 | $260.4K | 7,516 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 13,804 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 13,804 | — | $0 | 13,804 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 54,320 | — | $0 | 54,320 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 13,804 | — | $0 | 13,804 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 30,943 | $1.29 | $39.9K | 30,943 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 63,321 | — | $0 | 63,321 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2022-01-05 | 2022-01-07 | 4,428 | $9.03 | $40.0K | 4,428 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-11-11 | 2021-11-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-02-03 | 2021-02-05 | 77,399 | — | $0 | 77,399 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2020-12-04 | 2020-12-08 | 78,229 | — | $0 | 78,229 | SEC↗ |